CURIS INC cotiza a 0.64 USD y tiene una capitalización bursátil de $2M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small-molecule IRAK4 kinase inhibitor, which is in a Phase 1/2 open-label, single-arm expansion trial…
| Métrica | CRIS | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -60.5% | -38.6% | -21.9% |
| Net Margin | -80.3% | -33.6% | -46.7% |
| FCF Margin | — | -13.9% | — |
| ROE | -138.8% | -40.4% | -98.4% |
| ROA | -38.0% | -32.0% | -6.0% |
| Current Ratio | 0.49 | 2.84 | -2.35 |
| Debt / Equity | — | 0.28 | — |